5[14]Seki Y, Takahashi H, Shibata A, et al. Plasma levels of thrombomodulin and lipoprotein[a] in patients with cerebral thrombosis. Blood Coagul Fibrinolysis1997; 8:391
6[16]Kario K, Matsuo T, Kobayashi H, et al. "silent" cerebral infarction is associated with hypercoagulability, endothelial cell damage and high Lp[a] levels in elderly Japanese. Arterioscler Thromb Vasc Biol 1996; 16:734
7[17]Shinichiro U, Masako Y, Yukiko H, et al. Alteration of platelet, coagulation, and fibrinolysis markers in patients with acute ischemic stroke. Seminars Tromb Hem os1997; 23(6): 535 -41
8[18]Hideo T, Masahiro K, Kenichi T, et al. Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. Stroke 1990; 21:1663 - 7
9[5]Califano F, Giovanniello T, Pantone P, et al. Clinical importance of thrombomodulin serum levels. Eur Rev Med Pharmacol Sci 2000; 4(3): 59 - 66
10[6]Van der Bom JG, Bots, ML, Haverkate F, et al. Activation products of the hameostatic system in coronary, cerebrovascular and peripheral arterial disease. Thromb Haemost 2001; 85 (2): 234 - 9
